Skip to main content
. Author manuscript; available in PMC: 2007 Dec 1.
Published in final edited form as: Semin Oncol. 2006 Dec;33(6 Suppl 11):S50–S56. doi: 10.1053/j.seminoncol.2006.10.014

Figure 3.

Figure 3

FGF-BP expression in human and mouse dysplastic lesions. (A) Frequency of FGF-BP protein expression, analyzed by immunohistochemistry (IHC) with a polyclonal anti-FGFBP antibody in 161 human specimens ***P< 0.0001. (B) Frequency of FGF-BP mRNA expression in normal and dysplastic intestinal tissues obtained from B6 APCMin/+ mice. FGF-BP expression coincides with the activation of the beta-catenin pathway in this model **P< 0.001 (96).